Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-18 Sale |
2021-03-22 9:36 pm |
Bellerophon Therapeutics Inc. | BLPH | New Mountain Investments II LLC New Mountain Capital L.L.C. KLINSKY STEVEN B 10% Owner |
400,000 | $5.48 | $2,192,000 | 609,231 (Direct) |
View |
| 2020-09-10 Purchase |
2020-09-14 08:31 am |
Bellerophon Therapeutics Inc. | BLPH | FARES Wassim Chief Medical Officer |
4,000 | $10.18 | $40,708 | 4,000 (Direct) |
View |
| 2020-06-05 Purchase |
2020-06-09 4:01 pm |
Bellerophon Therapeutics Inc. | BLPH | Wang Theodore T Director 10% Owner |
7,586 | $12.77 | $96,896 | 60,913 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-10 Option Award |
2020-09-14 4:04 pm |
N/A 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | FARES Wassim Chief Medical Officer |
30,000 | $10.12 | 30,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:04 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Wang Theodore T Director 10% Owner |
6,509 | $10.12 | 13,806 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:03 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Teufel Crispin Director |
6,509 | $10.12 | 11,259 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:03 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Moura Andre V. Director |
6,509 | $10.12 | 13,472 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:03 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | BENNETT MATTHEW Director |
6,509 | $10.12 | 6,509 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:02 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Cloyd Mary Ann Director |
6,509 | $10.12 | 14,472 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:02 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Bruder Scott P Director |
6,509 | $10.12 | 15,138 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:02 pm |
2021-09-10 2030-09-10 |
Bellerophon Therapeutics Inc. | BLPH | Amin Naseem Director |
6,509 | $10.12 | 15,138 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-22 07:25 am |
N/A N/A |
Bellerophon Therapeutics Inc. | BLPH | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
1,153,846 | $13 | 1,153,846 (Direct) |
View |